Glenmark’s stock rises, standards for repurposed drugs must as well

The money matters first.  Indian pharma company Glenmark saw its share price trade at a new 52-week high on Monday, closing 27% higher. The rally was obviously on the back of the news it broke on Saturday that it had obtained “restricted use approval” for a drug called Favipiravir, to be used in mild to moderate … Read more Glenmark’s stock rises, standards for repurposed drugs must as well

Where does the H-1B ban hurt the most? It’s not an obvious answer

Donald Trump is readying himself to walk the presidential plank later this year. That’s why it makes sense that his administration would announce a ban on issuing any more H-1B, H-2B, and L-1 visas till 31 December, 2020.   Now, such news was bound to shock the Indian IT services sector to the core. Just … Read more Where does the H-1B ban hurt the most? It’s not an obvious answer

The gloom in India’s falling jobless rate

As the world’s longest and strictest lockdown is gradually relaxed, India’s job numbers have begun to improve. Its unemployment rate for the week ended 21 June was 8.5%—similar to pre-lockdown levels—according to the Centre for Monitoring Indian Economy (CMIE). This is a welcome fall from the peak of 27.1% in early May.    If the … Read more The gloom in India’s falling jobless rate